These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38847328)
1. USP15, activated by TFAP4 transcriptionally, stabilizes SHC1 via deubiquitination and deteriorates renal cell carcinoma. Shi Y; Zhang J; Li J; He J; Wu S; Yu M; Yang D; Ju L Cancer Sci; 2024 Aug; 115(8):2617-2629. PubMed ID: 38847328 [TBL] [Abstract][Full Text] [Related]
2. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation. Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730 [TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells. Li Z; Tian Y; Zong H; Wang X; Li D; Keranmu A; Xin S; Ye B; Bai R; Chen W; Yang G; Ye L; Wang S Apoptosis; 2024 Aug; 29(7-8):1051-1069. PubMed ID: 38553613 [TBL] [Abstract][Full Text] [Related]
4. SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis. Guo Z; Cai C; Zhou K; Song L; Wang X; Chen D; Weng G; Huang S Sci Rep; 2024 Aug; 14(1):20150. PubMed ID: 39209911 [TBL] [Abstract][Full Text] [Related]
5. PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC. Zhao Y; Wang Y; Zhao E; Tan Y; Geng B; Kang C; Li X Carcinogenesis; 2020 May; 41(3):274-283. PubMed ID: 31605605 [TBL] [Abstract][Full Text] [Related]
6. USP15 Enhances the Proliferation, Migration, and Collagen Deposition of Hypertrophic Scar-Derived Fibroblasts by Deubiquitinating TGF-βR1 In Vitro. Tu L; Lin Z; Huang Q; Liu D Plast Reconstr Surg; 2021 Nov; 148(5):1040-1051. PubMed ID: 34546211 [TBL] [Abstract][Full Text] [Related]
7. The deubiquitinase USP15 drives malignant progression of gastric cancer through glucose metabolism remodeling. Huangfu L; Zhu H; Wang G; Chen J; Wang Y; Fan B; Wang X; Yao Q; Guo T; Han J; Hu Y; Du H; Li X; Ji J; Xing X J Exp Clin Cancer Res; 2024 Aug; 43(1):235. PubMed ID: 39164728 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of USP15/MMP3 predict poor prognosis and promote growth, migration in non-small cell lung cancer cells. Chen W; Ni D; Zhang H; Li X; Jiang Y; Wu J; Gu Y; Gao M; Shi W; Song J; Shi W Cancer Genet; 2023 Apr; 272-273():9-15. PubMed ID: 36640492 [TBL] [Abstract][Full Text] [Related]
9. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma. Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633 [TBL] [Abstract][Full Text] [Related]
10. USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-κB signaling pathway. Li Y; Jiang C; Liu Q; Zhou P; Tian D; Zeng Y; Xiang M Aging (Albany NY); 2024 Mar; 16(8):6757-6772. PubMed ID: 38656882 [TBL] [Abstract][Full Text] [Related]
11. TRIM26 inhibits clear cell renal cell carcinoma progression through destabilizing ETK and thus inactivation of AKT/mTOR signaling. Zheng D; Ning J; Deng H; Ruan Y; Cheng F J Transl Med; 2024 May; 22(1):481. PubMed ID: 38773612 [TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific peptidase 15 regulates the TFAP4/PCGF1 axis facilitating liver metastasis of colorectal cancer and cell stemness. Yin H; Wu D; Qu Q; Li Z; Zhao L Biochem Pharmacol; 2024 Aug; 226():116319. PubMed ID: 38801926 [TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15. Teyra J; Singer AU; Schmitges FW; Jaynes P; Kit Leng Lui S; Polyak MJ; Fodil N; Krieger JR; Tong J; Schwerdtfeger C; Brasher BB; Ceccarelli DFJ; Moffat J; Sicheri F; Moran MF; Gros P; Eichhorn PJA; Lenter M; Boehmelt G; Sidhu SS Structure; 2019 Apr; 27(4):590-605.e5. PubMed ID: 30713027 [TBL] [Abstract][Full Text] [Related]
14. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway. Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025 [TBL] [Abstract][Full Text] [Related]
15. KIF15 upregulation promotes leiomyosarcoma cell growth via promoting USP15-mediated DEK deubiquitylation. Ge W; Chen Y; Guo Y; Zhao D; Mu L; Zhang K; Zhuo W Biochem Biophys Res Commun; 2021 Sep; 570():117-124. PubMed ID: 34280614 [TBL] [Abstract][Full Text] [Related]
16. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway. Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172 [TBL] [Abstract][Full Text] [Related]
17. Regulation of ubiquitin-proteasome system-mediated Tip110 protein degradation by USP15. Timani KA; Liu Y; Suvannasankha A; He JJ Int J Biochem Cell Biol; 2014 Sep; 54():10-9. PubMed ID: 24984263 [TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific peptidase 2 inhibits epithelial-mesenchymal transition in clear cell renal cell carcinoma metastasis by downregulating the NF-κB pathway. Duan J; Jin M; Yang D; Shi J; Gao J; Guo D; Tang H; Zhang S; Qiao B Bioengineered; 2022 Feb; 13(2):4455-4467. PubMed ID: 35152855 [TBL] [Abstract][Full Text] [Related]
19. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation. Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887 [TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]